• ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Consensus Recommendation of "Moderate Buy" by Brokerages MarketBeat Fri, 10 Jul 2026 06:21:18 GMT
• Insider Buying: CEO de Boer Daniel Anton Acquires 150,000 Shares of ProQR Therapeutics NV GuruFocus Wed, 08 Jul 2026 22:45:29 GMT
• ProQR (PRQR) CEO Daniel de Boer purchases 150,000 Ordinary Shares at $1.59 Stock Titan Wed, 08 Jul 2026 18:55:44 GMT
• ProQR Therapeutics files prospectus for 3.03M share offering scanx.trade Mon, 06 Jul 2026 23:20:17 GMT
• Oppenheimer Maintains ProQR Therapeutics(PRQR.US) With Buy Rating, Cuts Target Price to $1.81 Moomoo Mon, 06 Jul 2026 22:46:44 GMT
• ProQR Therapeutics (PRQR) registers 3.03M shares for resale on Nasdaq Stock Titan Mon, 06 Jul 2026 21:06:25 GMT
• ProQR prices $50M stock offering; secures $9.2M investment from Eli Lilly MSN Sun, 05 Jul 2026 22:28:56 GMT
• ProQR shows human pharmacological activity with RNA editing, backed by $59.2M funding for rare liver disease trials Pluang Sat, 04 Jul 2026 15:08:14 GMT
• ProQR Therapeutics: Human NTCP Data Strengthens The Axiomer Thesis (NASDAQ:PRQR) Seeking Alpha Sat, 04 Jul 2026 14:52:23 GMT
• Insider Buying: ProQR Therapeutics Independent Non-Executive Director Bought €231k Of Shares simplywall.st Thu, 02 Jul 2026 13:37:30 GMT
• prqr q1 2026 earnings: eps misses estimates as clinical-stage biotech advances pipeline - earnings preview dars.gov.et Wed, 01 Jul 2026 03:45:44 GMT
• Bart Filius Acquires 150,000 Shares of ProQR Therapeutics NV GuruFocus Tue, 30 Jun 2026 23:10:59 GMT
• Form 13D/A ProQR Therapeutics N.V. For: 30 June By Investing.com Investing.com Canada Tue, 30 Jun 2026 21:35:21 GMT
• Van Herk group reports 10.9% ProQR (PRQR) ownership after share issuances Stock Titan Tue, 30 Jun 2026 21:23:59 GMT
• Director Bart Filius buys 150,000 ProQR (PRQR) Ordinary Shares in open market Stock Titan Tue, 30 Jun 2026 20:01:37 GMT
• ProQR Therapeutics N.V. Actuals & Estimates (TRADEGATE:0PQ) TradingView Tue, 30 Jun 2026 09:29:36 GMT
• ProQR (PRQR) director receives 14,595-share option grant at $1.42 strike Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains proqr therapeutics(prqr.us) with buy rating, maintains target price $12 Moomoo Tue, 30 Jun 2026 06:55:10 GMT
• PRQR Maintained by Evercore ISI Group -- Price Target Raised to $6.00 GuruFocus Mon, 29 Jun 2026 16:04:29 GMT
• H.C. Wainwright Maintains ProQR Therapeutics(PRQR.US) With Buy Rating, Maintains Target Price $12 富途牛牛 Mon, 29 Jun 2026 13:33:00 GMT
• proqr prices $50m stock offering; secures $9.2m investment from eli lilly MSN Sat, 27 Jun 2026 09:34:27 GMT
• ProQR Raises $59 Million in Equity Offering and Eli Lilly Private Placement The Globe and Mail Sat, 27 Jun 2026 07:00:00 GMT
• proqr therapeutics (nasdaq: prqr) raises capital; lilly to purchase 5.1m shares Stock Titan Fri, 26 Jun 2026 18:55:01 GMT
• prqr maintains buy rating by jones trading -- price target lowered to $10.00 GuruFocus Fri, 26 Jun 2026 17:07:25 GMT
• proqr therapeutics price target cut to $10.00/share from $11.00 by jones trading Moomoo Fri, 26 Jun 2026 16:17:00 GMT
• PRQR Maintained by Chardan Capital -- Price Target Lowered to $3 GuruFocus Fri, 26 Jun 2026 13:50:57 GMT
• ProQR Therapeutics N.V. Actuals & Estimates (NASDAQ:PRQR) TradingView Fri, 26 Jun 2026 13:35:42 GMT
• small-cap proqr therapeutics secures funding from eli lilly on early trial success Sahm Fri, 26 Jun 2026 11:44:55 GMT
• price to book forward of proqr therapeutics n.v. – nasdaq:prqr TradingView Fri, 26 Jun 2026 09:04:35 GMT
• price to sales forward of proqr therapeutics n.v. – ls:a12b97 TradingView Fri, 26 Jun 2026 08:37:40 GMT
• proqr therapeutics nv (prqr) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 26 Jun 2026 08:28:10 GMT
• enterprise value to ebit forward of proqr therapeutics n.v. – ls:a12b97 TradingView Fri, 26 Jun 2026 08:13:09 GMT
• Key facts: ProQR AX-0810 NTCP Data; $50M Raise, Lilly Buys 5.1M TradingView Fri, 26 Jun 2026 07:13:42 GMT
• ProQR (PRQR) prices share offering and Eli Lilly private placement Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Chardan Research Adjusts ProQR Therapeutics Price Target to $3 From $4, Maintains Buy Rating marketscreener.com Fri, 26 Jun 2026 07:00:00 GMT
• ProQR prices $50M stock offering; secures $9.2M investment from Eli Lilly MSN Fri, 26 Jun 2026 07:00:00 GMT
• ProQR raises $50M after positive Phase 1 data, despite price target cut to $3.00 Pluang Fri, 26 Jun 2026 07:00:00 GMT
• chardan capital maintains proqr therapeutics(prqr.us) with buy rating, cuts target price to $3 Moomoo Fri, 26 Jun 2026 01:31:00 GMT
• proqr prices $50m stock offering; secures $9.2m investment from eli lilly MSN Thu, 25 Jun 2026 19:59:53 GMT
• Price to earnings forward of ProQR Therapeutics N.V. – NASDAQ:PRQR TradingView Thu, 25 Jun 2026 19:25:14 GMT
• proqr therapeutics reports positive phase 1 data for ax-0810 rna editing candidate grafa.com Thu, 25 Jun 2026 14:30:00 GMT
• proqr therapeutics (prqr) launches $50m share offering with eli lilly participation GuruFocus Thu, 25 Jun 2026 13:42:05 GMT
• proqr raises $50m through share offering and private placement with eli lilly to fund rna therapy development Pluang Thu, 25 Jun 2026 13:04:17 GMT
• ProQR prices $50M stock offering at $1.81 per share By Investing.com Investing.com Canada Thu, 25 Jun 2026 12:44:44 GMT
• proqr therapeutics prices $50 million underwritten registered direct offering marketscreener.com Thu, 25 Jun 2026 11:19:06 GMT
• proqr therapeutics nv announced that its investigational therapy ax-422 for mucopolysaccharidosis type i (mps1) is expected to sub... Bitget Thu, 25 Jun 2026 10:51:55 GMT
• proqr's $59m raise: a strategic bet on rna editing's future BriefGlance Thu, 25 Jun 2026 10:35:00 GMT
• proqr's rna editing breakthrough: a new dawn for liver disease treatment? BriefGlance Thu, 25 Jun 2026 10:25:00 GMT
• ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement GlobeNewswire Thu, 25 Jun 2026 07:00:00 GMT
• Small-Cap ProQR Therapeutics Secures Funding From Eli Lilly On Early Trial Success Benzinga Thu, 25 Jun 2026 07:00:00 GMT
• ProQR (PRQR) Phase 1 AX-0810 data clinically validate Axiomer RNA editing Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• ProQR Therapeutics (PRQR) Reports Progress in Phase 1 Study of A GuruFocus Thu, 25 Jun 2026 07:00:00 GMT
• ProQR’s first RNA editing drug shows human target engagement Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• ProQR reports positive Phase 1 data for AX-0810 in healthy volunteers Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• ProQR secures $50 million funding after positive AX-0810 data scanx.trade Thu, 25 Jun 2026 07:00:00 GMT
• ProQR raises $59.2M via direct offering and private placement scanx.trade Thu, 25 Jun 2026 07:00:00 GMT
• proqr therapeutics reports positive phase 1 target engagement data for ax-0810, supporting advancement of ntcp franchise Quiver Quantitative Thu, 25 Jun 2026 07:00:00 GMT
• proqr therapeutics (nasdaq: prqr) raises capital; lilly to purchase 5.1m shares Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• ProQR Therapeutics N.V. announced that it expects to receive $9.199996 million in funding from Eli Lilly and Company marketscreener.com Wed, 24 Jun 2026 07:00:00 GMT
• proqr therapeutics nv (prqr) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• proqr therapeutics nv (prqr) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 20:03:01 GMT
• proqr therapeutics nv (prqr) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 11:23:07 GMT
• ProQR Therapeutics NV (PRQR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 00:21:42 GMT
• proqr therapeutics nv (prqr) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 22:53:01 GMT
• proqr therapeutics nv (prqr) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 22:21:15 GMT
• proqr therapeutics nv (prqr) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 22:20:46 GMT
• proqr therapeutics nv (prqr) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 21:57:01 GMT
• proqr therapeutics nv (prqr) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 21:48:10 GMT
• proqr therapeutics nv (prqr) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• proqr therapeutics nv (prqr) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• proqr therapeutics nv (prqr) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• proqr therapeutics nv (prqr) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• ProQR Therapeutics Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue Phase, Stock Rises 5.9% - Share Repurchase Impact dars.gov.et Mon, 15 Jun 2026 07:00:00 GMT
• earnings preview: proqr (prqr) q1 earnings expected to decline Eastern Progress Mon, 15 Jun 2026 05:43:08 GMT
• ProQR Therapeutics (PRQR) Advances 3% as Biotech Sector Sentiment Improves - ETF Flow dars.gov.et Mon, 08 Jun 2026 07:00:00 GMT
• ProQR Therapeutics N.V. (PRQR) director awarded 14,495 stock options as compensation Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• proqr shareholders approve capital increase, board changes at 2026 agm The Globe and Mail Wed, 03 Jun 2026 07:00:00 GMT
• van herk group (nasdaq: prqr) challenges proqr 2026 agm share capital proposals Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• proqr therapeutics n.v. appoints lykke hinsch gylvin as non-executive member of the board, effective june 2, 2026 marketscreener.com Tue, 02 Jun 2026 20:01:00 GMT
• proqr (prqr) director hinsch gylvin lykke files form 3 with no share activity Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• proqr shareholders approve capital increase, board changes at 2026 agm TipRanks Tue, 02 Jun 2026 07:00:00 GMT
• proqr (prqr) backs new director, capital increase and share authorizations Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• prqr q1 2026 earnings: eps misses estimates as clinical-stage biotech maintains pipeline focus - analyst consensus shift dars.gov.et Mon, 01 Jun 2026 07:00:00 GMT
• proqr therapeutics q1 2026 earnings: loss slightly wider than estimates, pipeline progress under review newsline.com Mon, 01 Jun 2026 07:00:00 GMT
• proqr therapeutics (prqr) edges higher: a look at the biotech's recent price action - on balance volume newsline.com Fri, 29 May 2026 07:00:00 GMT
• prqr stock price, quote & chart | proqr therapeutics nv (nasdaq:prqr) ChartMill Fri, 29 May 2026 07:00:00 GMT
• proqr therapeutics holds steady above support; small uptick signals stability - sign of weakness newsline.com Thu, 28 May 2026 07:00:00 GMT
• proqr therapeutics (prqr) edges higher as shares approach key resistance levels - sentiment shift newsline.com Thu, 28 May 2026 07:00:00 GMT
• citizens reiterates proqr stock rating on biliary atresia potential by investing.com Investing.com Australia Wed, 27 May 2026 07:00:00 GMT
• ProQR Therapeutics (PRQR) Holds Steady Near $1.57 as Uplift Potential Remains - Analyst Upgrade Stocks dars.gov.et Tue, 26 May 2026 07:00:00 GMT
• proqr therapeutics (prqr) soars 8.3%: analyzing the rally and key levels to watch - analyst upgrade stocks newsline.com Mon, 25 May 2026 07:00:00 GMT
• proqr (prqr) eyes next move after holiday ahead of ax-0810 data Bez Kabli Sun, 24 May 2026 07:00:00 GMT
• proqr therapeutics q1 2026 earnings: narrower net loss, no revenue as pipeline progress drives stock gains - free cash flow trends... Newser Fri, 22 May 2026 20:30:32 GMT
• proqr therapeutics q1 2026 earnings: narrower loss on continued pipeline progress - full year guidance newsline.com Thu, 21 May 2026 07:00:00 GMT
• prqr stock price, quote & chart | proqr therapeutics nv (nasdaq:prqr) ChartMill Thu, 21 May 2026 07:00:00 GMT
• ProQR Therapeutics N.V. (PRQR) Presents at 29th ASGCT Annual Meeting 2026 - Slideshow Seeking Alpha Tue, 19 May 2026 07:00:00 GMT
• proqr (prqr) q1 2026 earnings miss by significant: key takeaways - earnings volatility report newsline.com Mon, 18 May 2026 07:00:00 GMT
• proqr therapeutics n.v. (prqr) presents at tides usa 2026 - slideshow (nasdaq:prqr) 2026-05-15 Seeking Alpha Sat, 16 May 2026 00:04:52 GMT
• proqr therapeutics n.v. - ordinary shares (nq: prqr The Chronicle-Journal Fri, 15 May 2026 20:00:01 GMT
• proqr therapeutics n.v. (prqr) presents at tides usa 2026 - slideshow (nasdaq:prqr) 2026-05-15 Seeking Alpha Fri, 15 May 2026 07:00:00 GMT
• proqr therapeutics n.v. - ordinary shares (nq: prqr FinancialContent Thu, 14 May 2026 14:39:37 GMT
• ProQR Therapeutics N.V. (NASDAQ:PRQR) Analysts Just Slashed This Year's Revenue Estimates By 22% Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• h.c. wainwright maintains proqr therapeutics(prqr.us) with buy rating, maintains target price $12 Moomoo Thu, 14 May 2026 07:00:00 GMT
• proqr: buy rating reiterated as axiomer pipeline progress and upcoming catalysts support unchanged $12 price target TipRanks Wed, 13 May 2026 15:37:51 GMT
• proqr posts wider q1 2026 loss but maintains strong cash position The Globe and Mail Wed, 13 May 2026 07:00:00 GMT
• h.c. wainwright maintains proqr therapeutics(prqr.us) with buy rating, maintains target price $12 Moomoo Wed, 13 May 2026 07:00:00 GMT
• proqr announces first quarter 2026 operating and financial results GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• chardan capital maintains proqr therapeutics(prqr.us) with buy rating, maintains target price $4 富途牛牛 Tue, 12 May 2026 07:00:00 GMT
• proqr posts wider q1 2026 loss but maintains strong cash position TipRanks Tue, 12 May 2026 07:00:00 GMT
• proqr (nasdaq: prqr) q1 2026 results, axiomer pipeline and cash runway Stock Titan Tue, 12 May 2026 07:00:00 GMT
• proqr posts q1 2026 results as axiomer rna editing pipeline advances TipRanks Tue, 12 May 2026 07:00:00 GMT
• proqr (nasdaq: prqr) updates ax-0810 strategy and q1 2026 results Stock Titan Tue, 12 May 2026 07:00:00 GMT
• rna editor proqr shifts ax-0810 to biliary atresia trial in china Stock Titan Tue, 12 May 2026 07:00:00 GMT
• proqr therapeutics n.v. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 12 May 2026 07:00:00 GMT
• ProQR Announces Multiple Upcoming Scientific Conference GlobeNewswire Mon, 11 May 2026 07:00:00 GMT
• proqr therapeutics n.v. - ordinary shares (nq: prqr The Chronicle-Journal Fri, 08 May 2026 20:00:01 GMT
• number of shareholders of proqr therapeutics n.v. – ls:a12b97 TradingView Thu, 07 May 2026 17:22:16 GMT
• Earnings Preview: ProQR (PRQR) Q1 Earnings Expected to Decline Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• proqr therapeutics (prqr) to release quarterly earnings on thursday MarketBeat Thu, 07 May 2026 07:00:00 GMT
• proqr forms advisory board, partnership with ginkgo as part of ai strategy MSN Tue, 05 May 2026 10:05:15 GMT
• ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders The Globe and Mail Tue, 05 May 2026 07:00:00 GMT
• proqr sets june 2 shareholder meeting, posts agenda documents online Stock Titan Mon, 04 May 2026 07:00:00 GMT
• proqr announces annual general meeting of shareholders to be held june 2, 2026 GlobeNewswire Mon, 04 May 2026 07:00:00 GMT
ProQR Therapeutics N.V(NASDAQ:PRQR) 
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It is primarily developing sepofarsen that is in phase II/III illuminate trial for treating leber's congenital amaurosis 10 disease; QR-421...
Website: http://www.proqr.com
Founded: 2012
Full Time Employees: 154
Sector: Healthcare
Industry: Biotechnology